Amprion

www.amprionme.com

๐—š๐—ฟ๐—ผ๐˜‚๐—ป๐—ฑ๐—ฏ๐—ฟ๐—ฒ๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—ณ๐—ผ๐—ฟ ๐—”๐—น๐˜‡๐—ต๐—ฒ๐—ถ๐—บ๐—ฒ๐—ฟ'๐˜€, ๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ป'๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—Ÿ๐—ฒ๐˜„๐˜† ๐—•๐—ผ๐—ฑ๐˜† ๐——๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ถ๐—ฎ. ๐—ช๐—ฒ ๐˜๐—ฟ๐—ฎ๐—ฐ๐—ธ ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฟ๐—ถ๐—ผ๐—ป ๐—ฏ๐—ถ๐—ผ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐—ฟ๐˜€ ๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ๐˜€๐—ฒ ๐—ฏ๐—ฟ๐—ฎ๐—ถ๐—ป ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€. Amprion pioneers Prion Early Detection Testingโ„  for Alzheimerโ€™s and Parkinsonโ€™s. For the first time in history, our proprietary molecular-based diagnostic technology tracks the biomarkers, aka prions including Abeta, Tau and Synuclein, that drive Alzheimerโ€™s and Parkinsonโ€™s prior to any clinical symptoms. Currently awarded FDA Breakthrough Device Designation for the detection of misfolded Synuclein, a biomarker for Parkinsonโ€™s, the company is also applying the same assay to detect misfolded Abeta and Tau, which are known to cause Alzheimerโ€™s. Amprion expects to obtain FDA approvals in the next 18 months and to launch various early detection testing for Alzheimerโ€™s and Parkinsonโ€™s accordingly. Early diagnosis of Alzheimerโ€™s and Parkinsonโ€™s empowers us to find a cure to stop these diseases on their tracks. Learn more about ParkinZheimerโ€”our philosophy and a pillar of our scientific discoveryโ€”Alzheimerโ€™s and Parkinsonโ€™s are two related diseases on a spectrum: https://www.amprionme.com/our-philosophy/ Join us in the fight for brain health. Sign up for email alerts on our latest breakthroughs: https://www.amprionme.com/join-the-fight/ == About FDA Breakthrough Device Designation === FDAโ€™s Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. == How Amprion Works === Amprionโ€™s breakthrough early testing for Alzheimer's and Parkinson's tracks the prion biomarkers, using spinal fluid (CSF) and/or blood. Learn more at https://AmprionMe.com. Join the Fight For Brain Health #BrainHealth

Read more

Reach decision makers at Amprion

Lusha Magic

Free credit every month!

๐—š๐—ฟ๐—ผ๐˜‚๐—ป๐—ฑ๐—ฏ๐—ฟ๐—ฒ๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—ณ๐—ผ๐—ฟ ๐—”๐—น๐˜‡๐—ต๐—ฒ๐—ถ๐—บ๐—ฒ๐—ฟ'๐˜€, ๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ป'๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—Ÿ๐—ฒ๐˜„๐˜† ๐—•๐—ผ๐—ฑ๐˜† ๐——๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ถ๐—ฎ. ๐—ช๐—ฒ ๐˜๐—ฟ๐—ฎ๐—ฐ๐—ธ ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฟ๐—ถ๐—ผ๐—ป ๐—ฏ๐—ถ๐—ผ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐—ฟ๐˜€ ๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ๐˜€๐—ฒ ๐—ฏ๐—ฟ๐—ฎ๐—ถ๐—ป ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€. Amprion pioneers Prion Early Detection Testingโ„  for Alzheimerโ€™s and Parkinsonโ€™s. For the first time in history, our proprietary molecular-based diagnostic technology tracks the biomarkers, aka prions including Abeta, Tau and Synuclein, that drive Alzheimerโ€™s and Parkinsonโ€™s prior to any clinical symptoms. Currently awarded FDA Breakthrough Device Designation for the detection of misfolded Synuclein, a biomarker for Parkinsonโ€™s, the company is also applying the same assay to detect misfolded Abeta and Tau, which are known to cause Alzheimerโ€™s. Amprion expects to obtain FDA approvals in the next 18 months and to launch various early detection testing for Alzheimerโ€™s and Parkinsonโ€™s accordingly. Early diagnosis of Alzheimerโ€™s and Parkinsonโ€™s empowers us to find a cure to stop these diseases on their tracks. Learn more about ParkinZheimerโ€”our philosophy and a pillar of our scientific discoveryโ€”Alzheimerโ€™s and Parkinsonโ€™s are two related diseases on a spectrum: https://www.amprionme.com/our-philosophy/ Join us in the fight for brain health. Sign up for email alerts on our latest breakthroughs: https://www.amprionme.com/join-the-fight/ == About FDA Breakthrough Device Designation === FDAโ€™s Breakthrough Devices Program is designed to speed up development, assessment and review of medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. == How Amprion Works === Amprionโ€™s breakthrough early testing for Alzheimer's and Parkinson's tracks the prion biomarkers, using spinal fluid (CSF) and/or blood. Learn more at https://AmprionMe.com. Join the Fight For Brain Health #BrainHealth

Read more
icon

Country

icon

State

California

icon

City (Headquarters)

San Francisco

icon

Employees

11-50

icon

Founded

2007

icon

Estimated Revenue

$1,000,000 to $5,000,000

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Operating Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Commercial Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Marketing Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Chief Executive Officer

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(41)

Reach decision makers at Amprion

Free credits every month!

My account

Amprion FAQ

Sign up now to uncover all the contact details